Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
11131680 · 2021-09-28
Assignee
Inventors
Cpc classification
B01L2300/0636
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0627
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
G01N33/86
PHYSICS
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L3/52
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/86
PHYSICS
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The present invention is directed to a cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, in particular a blood sample, comprising a cartridge body having at least one measurement cavity formed therein and having at least one probe element arranged in said at least one measurement cavity for performing a test on said sample liquid; and a cover being attachable on said cartridge body; wherein said cover covers at least partially said at least one measurement cavity and forms a retaining element for retaining said probe element in a predetermined position within said at least one measurement cavity. The invention is directed to a measurement system and a method for measuring viscoelastic characteristics of a sample liquid.
Claims
1. An apparatus for determining at least one viscoelastic characteristic associated with a test sample, comprising: a cartridge body that is configured to couple to a system, wherein the cartridge body comprises a plurality of test chambers, and wherein the system comprises a control apparatus to control testing in the plurality of test chambers to determine the at least one viscoelastic characteristic associated with the test sample; the plurality of test chambers including a first test chamber, a second test chamber, and a third test chamber that are each at least partially defined by the cartridge body; and fluid pathways to transport mixtures based on parts of the test sample, wherein respective fluid pathways are in fluid communication with the first test chamber, the second test chamber, and the third test chamber to deliver respective mixtures produced by mixing a reagent and part of the test sample to each of the first test chamber, the second test chamber, and the third test chamber; wherein each of the plurality of test chambers including the first, second, and third test chambers, is configured to receive, via a respective fluid pathway, a respective mixture that is based on blood of the test sample, each mixture being for testing to determine the at least one viscoelastic characteristic; wherein a first mixture received in the first test chamber is based on a first reagent, or a first combination of reagents, and blood of the test sample, wherein the first reagent, or a reagent included in the first combination of reagents, is to activate coagulation via an extrinsic or intrinsic pathway; wherein a second mixture received in the second test chamber is based on a second reagent, or a second combination of reagents, and blood of the test sample, wherein the second reagent, or a reagent included in the second combination of reagents, includes i) a reagent to activate coagulation via the extrinsic or intrinsic pathway or ii) a reagent to inhibit platelet function; wherein a third mixture received in the third test chamber is based on a third reagent, or a third combination of reagents, and blood of the test sample, wherein the third reagent, or a reagent included in the third combination of reagents, is to activate coagulation via the extrinsic or intrinsic pathway; wherein the cartridge body comprises a first reagent chamber, a second reagent chamber, and a third reagent chamber for holding, respectively, the first reagent or the first combination of reagents, the second reagent or the second combination of reagents, and the third reagent or the third combination of reagents; and wherein the fluid pathways comprise: a first channel in fluid communication with the first test chamber for delivering the first mixture into the first test chamber; a second channel in fluid communication with the second test chamber for delivering the second mixture into the second test chamber; and a third channel in fluid communication with the third test chamber for delivering the third mixture into the third test chamber.
2. The apparatus of claim 1, wherein testing in at least one of the first test chamber, the second test chamber, or the third test chamber is based on coagulation associated with at least one of the first mixture, the second mixture, or the third mixture, respectively.
3. The apparatus of claim 1, wherein at least one of the first reagent, the second reagent, or the third reagent is stored within the cartridge body in solid form prior to interacting with a part of the test sample.
4. The apparatus of claim 1, wherein the cartridge body defines at least a portion of each fluid pathway.
5. The apparatus of claim 1, wherein the cartridge body comprises plastic.
6. The apparatus of claim 1, wherein the testing comprises an assessment of at least one of coagulation, platelets, or fibrinolysis.
7. The apparatus of claim 1, wherein at least two of the first reagent, the second reagent, or the third reagent comprise different reagents to activate or to suppress different parts of the coagulation cascade.
8. The apparatus of claim 1, wherein at least three tests are performed using the first test chamber, the second test chamber, and the third test chamber.
9. The apparatus of claim 1, wherein the fluid pathways comprise the first channel in which the first reagent, or the first combination of reagents, are combined with the blood of the test sample prior to the first mixture being delivered to the first test chamber.
10. The apparatus of claim 1, wherein the first reagent, or the first combination of reagents, is for INTEM or EXTEM; and wherein the second reagent, or the second combination of reagents, is for FIBTEM.
11. The apparatus of claim 1, further comprising: a first pressure-controlled stop to inhibit entry of blood of the test sample into the first reagent chamber; a second pressure-controlled stop to inhibit entry of blood of the test sample into the second reagent chamber; and a third pressure-controlled stop to inhibit entry of a blood of the test sample into the third reagent chamber.
12. The apparatus of claim 1, wherein the fluid pathways comprise a first fluid pathway connected to the first test chamber for producing and transporting the first mixture, a second fluid pathway connected to the second test chamber for producing and transporting the second mixture, and a third fluid pathway connected to the third test chamber for producing and transporting the third mixture; and wherein the first fluid pathway comprises the first channel, the second fluid pathway comprises the second channel, and the third fluid pathway comprises the third channel.
13. The apparatus of claim 12, wherein the first fluid pathway comprises a first receiving chamber for receiving first blood of the test sample usable to produce the first mixture, the second fluid pathway comprises a second receiving chamber for receiving second blood of the test sample usable to produce the second mixture, and the third fluid pathway comprises a third receiving chamber for receiving third blood of the test sample usable to produce the third mixture.
14. The apparatus of claim 12, wherein the first fluid pathway is configured to receive first blood of the test sample from a bottom of another chamber.
15. The apparatus of claim 1, wherein the first reagent chamber, the second reagent chamber, and the third reagent chamber are configured to receive blood of the test sample in response to a change in pressure.
16. The apparatus of claim 1, further comprising: a probe element in the first test chamber, the probe element for rotating within the first mixture to rotate a mirror, where rotation of the mirror is based on a viscoelastic characteristic of the first mixture.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The figures are showing the following:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
DESCRIPTION OF EXEMPLARY EMBODIMENTS
(26) Parts and components having same functions are depicted with same references.
(27) Prior to a detailed description of the preferred embodiments the basic features and a basic practical implementation are summoned as follows. All embodiments refer to a cartridge device 50 (see
(28) A first embodiment of a cartridge device 50 of the invention will be described with reference to
(29) In this embodiment the receiving cavity 16 consists of a cavity within the cartridge device 50. The sample liquid 1 can be applied by means of a syringe, pipette etc, e.g. through a self sealing cap shown as a receiving cavity cover 33a in
(30) In an alternative embodiment the reagent cavity 19 is integral formed with the pump means 18 and/or with the measurement cavity 20 and/or with the ductwork. The transport of the sample liquid 1 can be controlled by said control apparatus.
(31)
(32) It is apparent to a person skilled in the art that in order to achieve a maximum benefit for a user different types of tests can be combined in one cartridge device 50.
(33) In a preferred embodiment the cartridge device 50 comprises four arrangements of
(34) Regarding e.g. blood coagulation there are different reagents available which activate or suppress different parts of the coagulation cascade. Pentapharm GmbH (Munich, Germany) for example amongst others provide tests for intrinsic and extrinsic activation of a blood sample (INTEM or EXTEM respectively), and also a test for extrinsic activation in which the thrombocyte function is suppressed by administration of cytochalasin D (FIBTEM). It is state of the art that it is possible by wise combination of such tests to be able to determine very precisely at which point within the coagulation cascade a problem occurs. This is of great importance in order to determine a proper medication. By comparison of the results on an EXTEM test of a pathologic sample to those of a FIBTEM test of the same sample it is possible to e.g. precisely determine if a coagulation disorder results from lack of fibrinogen or a malfunction of platelets. Generally, there are different typical medical scenarios in which coagulation disorders are very likely to occur. For example coagulation disorders occurring during liver transplantation are merely caused by lack of certain coagulation factors etc., while coagulation disorders during open heart surgery are most likely due to the influence of heparin. This means basically that different medical settings require different coagulation tests. Referring to
(35) It is important to note that the cartridge devices 50 of the described embodiments are suitable for different diagnostic tests like thromboelastometry, thromboelastography, platelet aggregometry and others. Depending on which type of test or tests the cartridge device 50 is designed for, there are different additional parts required which interact with the sample during measurement and/or an external control apparatus. Possible adaptations for thromboelastometry and platelet aggregometry are described below.
(36)
(37) The probe element 22 comprises the probe pin 3 (see
(38) The probe element 22 is arranged in the measurement cavity 20 of the cartridge body 30 of the cartridge device 50 as shown in
(39) During attaching the cartridge device 50 to the measuring system 40 (see also
(40) It is also possible to insert the insert section 6a of the shaft 6 into the connector section 26 of the probe element 22 and push the probe element 22 down until its bottom contacts the bottom of the measurement cavity 20, 20′ ensuring that the insert section 6a is completely inserted into the connector section 26. Then the shaft 6 will be moved up into the measuring resp. working position of the probe element 22 as shown in
(41)
(42) Now a third embodiment of the cartridge device 50 will be described with reference to
(43)
(44) The cartridge device 50 of this example is equipped with the ductwork 13 and 15. The ducts are formed with an diameter of approximately 1 mm in this embodiment. The ductwork requires that the cartridge device 50 comprises two parts: the cartridge body 30 and the cover 31, which are glued or welded together to obtain a leak-proof device. The cartridge body 30 is relative rigid and the cover 31 is formed as an elastic part. So it is possible to integrate the pump means 18 into the cover 31. Moreover, the cover 31 covers the receiving cavity 16 with the receiving cavity cover 33a and forms a type of liner wall 33 and a separation wall 34 forming an inlet for the inlet duct 13 within the receiving cavity 16. The receiving cavity cover 33a might act as a self seal for injection of a sample liquid 1 by a syringe for example. The cover 31 forms top parts of the ductwork 13 an 15 and a cover of the measurement cavity 20 (see also
(45) In this embodiment a reagent cavity 19, 19′ is formed, e.g. by sections of the ductwork or/and the pump means 18, 18′ in which the reagents can be stored resp. deposited, especially on the pump cavity bottom 36a, for example.
(46) The pump means 18 will now be described with reference to
(47)
(48) In this example the pump cavity 36 is connected to the inlet duct 13 via an inlet valve 37 and to the outlet valve via an outlet valve 38. Actuation of the pump membrane 35 (shown in
(49) An external force exerted on the pump membrane 35 increase the pressure within the pump cavity 36 and opens outlet valve 38 and closes inlet valve 37. Releasing the external force the elastic pump membrane 35 returns into the position shown in
(50) Now the measuring system 40 according to the invention is described in an embodiment with reference to
(51)
(52) The measuring system 40 comprises an interface element 41 to which the cartridge device 50 is attached and fixed. The interface element 41 is shown in
(53)
(54) Thus it is possible to e.g. arrange a reagent receptacle 19b in a blister receptacle e.g. as shown in
(55) It is also possible to insert reagent receptacles into provided cavities being connected to the ductwork. The reagents can be designed as globules with an appropriate diameter so that they cannot flow through openings into the ductwork before being dissolved by the sample liquid.
(56)
LIST OF REFERENCE NUMERALS
(57) 1 Sample liquid
(58) 2 Cup
(59) 3 Probe pin
(60) 4 Torsion wire
(61) 5 Rotation axis
(62) 6 Shaft
(63) 6a Insert section
(64) 7 Bearing
(65) 8 Mirror
(66) 9 Spring
(67) 10 Detecting means
(68) 11 Base plate
(69) 12 Cup holder
(70) 13, 13′ Inlet duct
(71) 14, 14 Intermediate duct
(72) 15, 15′ Outlet duct
(73) 16, 16′ Receiving cavity
(74) 17 Branch duct
(75) 18, 18′ Pump means
(76) 19,19′ Reagent cavity
(77) 19a, 19′a Regent cavity bottom
(78) 19b Reagent receptacle
(79) 20, 20′ Measurement cavity
(80) 21, 21′ Reagent
(81) 22, 22′ Probe element
(82) 23 Intermediate section
(83) 24 Flange
(84) 25 Fixing section
(85) 26 Connector section
(86) 27 Insertion guide
(87) 28 Groove
(88) 29 Dimple
(89) 29a Nose
(90) 30 Cartridge body
(91) 31 Cover
(92) 32 Fixing means
(93) 32a Opening
(94) 33 Wall
(95) 33a Receiving cavity cover
(96) 34 Separation wall
(97) 35 Pump membrane
(98) 36 Pump cavity
(99) 36a Pump cavity bottom
(100) 37 Inlet valve
(101) 38 Outlet valve
(102) 39 Flow direction
(103) 40 Measuring system
(104) 41 Interface element
(105) 42 Pump access
(106) 43 inlet opening
(107) 44 Shaft passage
(108) 44a Passage hole
(109) 45 Reagent cover opening
(110) 46 Retaining ring
(111) 47 Frame
(112) 48 Bottom foil
(113) 49 Blister cover
(114) 50 Cartridge device